Mirum Pharmaceuticals, Inc. (MIRM)
86.06
+0.05
(+0.06%)
USD |
NASDAQ |
Oct 12, 16:00
86.00
-0.06
(-0.07%)
After-Hours: 07:50
Mirum Pharmaceuticals Net Income (TTM) : -860.21M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -860.21M |
| March 31, 2026 | -798.84M |
| December 31, 2025 | -23.36M |
| September 30, 2025 | -41.42M |
| June 30, 2025 | -58.56M |
| March 31, 2025 | -77.34M |
| December 31, 2024 | -87.94M |
| September 30, 2024 | -97.30M |
| June 30, 2024 | -106.65M |
| March 31, 2024 | -156.05M |
| December 31, 2023 | -160.90M |
| September 30, 2023 | -164.19M |
| June 30, 2023 | -176.30M |
| March 31, 2023 | -129.19M |
| Date | Value |
|---|---|
| December 31, 2022 | -135.66M |
| September 30, 2022 | -41.69M |
| June 30, 2022 | -53.09M |
| March 31, 2022 | -70.06M |
| December 31, 2021 | -83.99M |
| September 30, 2021 | -178.74M |
| June 30, 2021 | -153.14M |
| March 31, 2021 | -132.49M |
| December 31, 2020 | -103.27M |
| September 30, 2020 | -84.02M |
| June 30, 2020 | -77.60M |
| March 31, 2020 | -67.91M |
| December 31, 2019 | -52.55M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Incyte Corp. | 1.612B |
| Insmed, Inc. | -875.31M |
| Galectin Therapeutics, Inc. | -27.84M |
| Kodiak Sciences, Inc. | -241.99M |
| Praxis Precision Medicines, Inc. | -339.13M |